Search - tctmd.com

Displaying 181 - 200 of 500

Sort: Relevancy | Date

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Daily News

Criminalizing Stent Cases? The 70/30 Rule Must Go, Experts Say

Todd Neale

January 06, 2020

News Daily News

SCAI Experts Update Transradial Guidance

Yael L. Maxwell

January 03, 2020

News Daily News

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

Todd Neale

December 23, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Yael L. Maxwell

October 16, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Daily News

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

Caitlin E. Cox

September 20, 2019

News Industry News

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

July 23, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

Advertisement

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Criminalizing Stent Cases? The 70/30 Rule Must Go, Experts Say

SCAI Experts Update Transradial Guidance

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Repeat Target-Lesion PCI: An Option for Public Reporting?

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content